| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5446194 | ORION PHARMA | Pharmacologically active catechol derivatives |
Oct, 2013
(10 years ago) | |
| US6599530 | ORION PHARMA | Oral compacted composition comprising catechol derivatives |
Sep, 2018
(5 years ago) | |
Comtan is owned by Orion Pharma.
Comtan contains Entacapone.
Comtan has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Comtan are:
- US5446194
- US6599530
Comtan was authorised for market use on 19 October, 1999.
Comtan is available in tablet;oral dosage forms.
Comtan can be used as treatment of parkinson's disease.
The generics of Comtan are possible to be released after 14 September, 2018.
Drugs and Companies using ENTACAPONE ingredient
Market Authorisation Date: 19 October, 1999
Treatment: Treatment of parkinson's disease
Dosage: TABLET;ORAL
How can I launch a generic of COMTAN before it's drug patent expiration?
More Information on Dosage
COMTAN family patents
